Literature DB >> 12799020

Interleukin-6, beta-amyloid peptide and NMDA interactions in rat cortical neurons.

Zhihua Qiu1, Donna L Gruol.   

Abstract

Neuronal damage in Alzheimer's disease (AD) is thought to involve direct toxicity of beta-amyloid peptide (Abeta) and excitotoxicity involving NMDA receptors (NMDARs) and altered Ca(2+) dynamics. Inflammation agents produced by microglia or astrocytes and associated with senile plaques such as the cytokine interleukin-6 (IL-6) could also contribute. To investigate this possibility, neuronal damage (lactate dehydrogenase assay, LDH, assay) was measured in cultures of rodent cortical neurons chronically treated with IL-6, Abeta or Abeta plus IL-6 and acutely treated with NMDA. Both Abeta and NMDA produced neuronal damage and this effect was larger with combined treatment. IL-6 did not produce significant neuronal damage but the largest neuronal damage was observed in cultures exposed to all three factors. IL-6 and Abeta enhanced Ca(2+) responses to NMDA and combined treatment produced the largest effect. These results are consistent with a role for interactions between Abeta, NMDA and IL-6 in the neuronal loss in AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799020     DOI: 10.1016/s0165-5728(03)00158-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  22 in total

Review 1.  Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease.

Authors:  Grace E Stutzmann; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

Review 2.  The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ.

Authors:  Cong Zheng; Xin-Wen Zhou; Jian-Zhi Wang
Journal:  Transl Neurodegener       Date:  2016-04-05       Impact factor: 8.014

3.  Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.

Authors:  Xiao-Xia Fang; Xiao-Lin Jiang; Xin-Hua Han; Yu-Ping Peng; Yi-Hua Qiu
Journal:  Cell Mol Neurobiol       Date:  2012-11-16       Impact factor: 5.046

4.  Chronic alcohol-induced liver injury correlates with memory deficits: Role for neuroinflammation.

Authors:  Jean A King; Benjamin C Nephew; Asmita Choudhury; Guillaume L Poirier; Arlene Lim; Pranoti Mandrekar
Journal:  Alcohol       Date:  2019-08-06       Impact factor: 2.405

5.  Crosstalk Among Disrupted Glutamatergic and Cholinergic Homeostasis and Inflammatory Response in Mechanisms Elicited by Proline in Astrocytes.

Authors:  Samanta Oliveira Loureiro; Daniele Susana Volkart Sidegum; Helena Biasibetti; Mery Stefani Leivas Pereira; Diogo Losch de Oliveira; Regina Pessoa-Pureur; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2015-01-13       Impact factor: 5.590

6.  Interleukin-6 inhibits L-type calcium channel activity of cultured cerebellar granule neurons.

Authors:  Song-Hua Ma; Bing Li; Hui-Wei Huang; Yu-Ping Peng; Yi-Hua Qiu
Journal:  J Physiol Sci       Date:  2012-06-14       Impact factor: 2.781

7.  Neuroprotection of interleukin-6 against NMDA-induced apoptosis and its signal-transduction mechanisms.

Authors:  Zhan Liu; Yi-Hua Qiu; Bing Li; Song-Hua Ma; Yu-Ping Peng
Journal:  Neurotox Res       Date:  2010-08-18       Impact factor: 3.911

Review 8.  Genetic predisposition to inflammation: a new risk factor of Alzheimer's disease.

Authors:  Ying Wan; Gang Wang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2008-10       Impact factor: 5.203

Review 9.  Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?

Authors:  Rohit Kumar Tiwari; Afrasim Moin; Syed Mohd Danish Rizvi; Syed Monowar Alam Shahid; Preeti Bajpai
Journal:  Metab Brain Dis       Date:  2021-03-11       Impact factor: 3.584

Review 10.  Interleukin-6, a major cytokine in the central nervous system.

Authors:  María Erta; Albert Quintana; Juan Hidalgo
Journal:  Int J Biol Sci       Date:  2012-10-25       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.